Merck Sharp and Dohme LLC, (a subsidiary of Merck & Co. Inc., Rahway, New Jersey, USA)/ â€œA phase 2b Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis.

Open for enrollment

(956) 362-8074

Please contact us for more information or to learn if you are eligible to participate.

This research trial is testing an experimental drug called MK-3655 in people with liver disease called nonalcoholic steatohepatitis (NASH).

5323 S. McColl Rd., Edinburg, TX 78539

(956) 362-2390